Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 16/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7566064 | 0.98 | AKR1B1 (0.62) | AKR1B1KDM1AHSD11B1ALDH1A1GAA | |
| SCHEMBL7566907 | 0.88 | AKR1B1 (0.57) | AKR1B1HSD11B1ALDH1A1GAA | |
| SCHEMBL9394789 | 0.85 | AKR1B1 (0.47) | AKR1B1KDM1AHSD11B1 | |
| Lithium Ion SCHEMBL7565191 | 0.84 | AKR1B1 (0.46) | AKR1B1KDM1A | |
| SCHEMBL9392173 | 0.80 | AKR1B1 (0.51) | AKR1B1KDM1A | |
| SCHEMBL9391406 | 0.80 | AKR1B1 (0.51) | AKR1B1KDM1A | |
| SCHEMBL2697131 | 0.79 | AKR1B1 (0.42) | AKR1B1KDM1AALDH1A1 | |
| SCHEMBL7565508 | 0.76 | AKR1B1 (0.50) | AKR1B1HSD11B1ALDH1A1GAA | |
| SCHEMBL8361398 | 0.74 | AKR1B1 (0.48) | AKR1B1 | |
| SCHEMBL8361281 | 0.74 | AKR1B1 (0.48) | AKR1B1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0987248-B1 | Amide derivatives and their therapeutic use | WELLCOME FOUND (GB) | 2002-09-04 | — | — | EP | disclosed |
| EP-0699180-B1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | WELLCOME FOUND (GB) | 2000-11-22 | — | — | EP | disclosed |
| US-6124284-A | REDUCED SIDE EFFECTS | GLAXO WELLCOME INC. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-0987248-A1 | Amide derivatives and their therapeutic use | THE WELLCOME FOUNDATION LIMITED (GB) | 2000-03-22 | — | — | EP | disclosed |
| EP-0759025-B1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | WELLCOME FOUND (GB) | 1999-07-21 | — | — | EP | disclosed |
| US-5872118-A | RELAXATION OF SKELETAL MUSCLE IN SPASTIC, HYPERTONIC AND HYPERKINETIC CONDITIONS | GLAXO WELLCOME INC. (US) | 1999-02-16 | — | — | US | disclosed |
| US-5719186-A | CENTRAL MUSCLE RELAXANTS, ANXIOLYTIC AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTICONVULSANTS | GLAXO WELLCOME INC. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1994026692-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | disclosed |